Friday, January 21, 2011

High Physical Activity Enable Osteoarthritis People Walk Faster


Increased physical activity enables people with knee osteoarthritis to walk faster, says a research conducted by Northwestern University. "The more active people are, the faster they can walk," said Dorothy Dunlop, associate professor of medicine at Northwestern University Feinberg School of Medicine and lead author of the study


Enable Osteoarthritis People Walk Faster
"This is strong evidence that even a small increase in activity is related to better walking function. The bar for improvement isn't that high. This should motivate people to get moving, even if they have pain or stiffness." 



Federal guidelines recommend adults with arthritis should participate in at least 2.5 hours a week of moderate intensity, low-impact activity in sessions lasting 10 minutes or more. Even if people can't meet these levels, Dunlop said they should be as physically active as possible. 
The Osteoarthritis Initiative, an observational study, surveyed 2,500 participants with knee osteoarthritis. Participants filled out self-reported questionnaires about their physical activity at sites in Columbus, Ohio, Baltimore, Md., Providence, R.I., and Pittsburgh, Pa. 

Researchers divided participants into four physical activity groups, from lowest to highest, using a general activity score. In the lowest physical activity group, less than half, or 49 percent, walked fast enough to cross the street before the light changed. (Traffic lights generally allow a walking speed of four feet per second.) In the next three higher physical activity groups, 63 percent, 71 percent and 81 percent, respectively, walked fast enough to cross the street. 

Monday, January 17, 2011

Virus Might Fight If Armed With Bacterial Enzyme, Study Shows

New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumors if equipped with an enzyme that helps them penetrate the tumor.

The enzyme, called chondroitinase, helps the cancer-killing virus clear its way through the thickets of protein molecules that fill space between cells and impede the virus's movement through the tumor, say researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute who conducted the study.

Brain Tumors Better Study Shows


When tested in animals transplanted with a human glioblastoma, the most common and deadly form of brain cancer, the enzyme-armed virus improved survival by 52 percent compared with controls and in some cases eliminated the tumor entirely. The findings were published online in the journal Clinical Cancer Research. "Our results show for the first time that an oncolytic virus with this enzyme can spread more effectively through the tumor and underscores the potential of using chondroitinases to enhance the capacity of oncolytic viruses to destroy cancer cells," says study leader Balveen Kaur, associate professor of neurological surgery.

The enzyme is derived from the intestinal bacteria called Proteus vulgaris. The enzyme removes sugar chains that branch from molecules called proteoglycans, which fill the narrow spaces between cells. By cutting away these branches, the enzyme clears a path that helps the virus spread through the tumor.

During this study, Kaur and her collaborators injected human glioblastoma cells under the skin of eight animals, and then, after tumors developed, treated the tumors with the enzyme-armed virus. These mice survived an average of 28 days, with two remaining tumor-free after 80 days. Control animals, treated with a virus that lacked the enzyme, survived 16 days.

In another experiment, mice with human gliobastomas transplanted into the brain survived 32 days versus 21 days for control animals, an improvement of 52 percent. Again, two animals lived more than 80 days and showed no trace of the tumor afterward. Additional studies showed that the enzyme-laden virus had penetrated tumors in the animals' brain significantly better than the enzyme-free control virus. "Overall, our results indicate that an oncolytic virus armed with this enzyme can have a significantly greater anticancer effect compared with a similar virus without the enzyme," Kaur says.

Funding from the National Institute for Neurological Disorders and Stroke supported this research.  Other researchers involved in this study were Nina Dmitrieva, Lianbo Yu, Mariano Viapiano and E. Antonio Chiocca of Ohio State University; Timothy P. Cripe of Cincinnati Children's Hospital Medical Center and the University of Cincinnati, and J. Glorioso of the University of Pittsburgh.

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (http://cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 205-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.

Monday, January 10, 2011

Prozac 'helps stroke patients recover from paralysis'

A new study has found that giving stroke patients antidepressant pill Prozac soon after the event, could help their recovery from paralysis. Researchers have shown more improvement in movement and greater independence after 3 months in patients taking the antidepressant (also known as fluoxetine), compared to a placebo, reports BBC News.

Recovery from paralysis



The study was based on research on 118 patients in France, who had moderate to severe motor disabilities following their stroke.Tests on stroke patients 90 days after being given the drug found that patients taking fluoxetine had gained significantly more function in their upper and lower limbs than patients who were not given the drug.

Patients in the fluoxetine group were also more likely to be coping independently. The study noted that the side-effects from the antidepressant were generally mild and infrequent, although this group did notice more instances of nausea and diarrhea.

The findings were reported in the journal Lancet Neurology.

Friday, January 7, 2011

Republicans Are Given a Price Tag for Health Law Repeal, but Reject It

WASHINGTON — The nonpartisan budget scorekeepers in Congress said on Thursday that the Republican plan to repeal President Obama’s health care law would add $230 billion to federal budget deficits over the next decade, intensifying the first legislative fight of the new session and highlighting the challenge Republicans face in pursuing their agenda. 


Given a Price Tag for Health Law Repeal, but Reject It



The new House speaker, John A. Boehner, flatly rejected the report, saying it was based largely on chicanery by Democrats. Mr. Boehner’s dismissal of the report by the Congressional Budget Office, at his first formal news conference as speaker, was the latest salvo in the battle over the health care law. White House officials on Thursday said they were stepping up efforts to defend the law, with a new rapid-response operation to rebut Republican claims and to deploy supporters to talk about the benefits of the law. But Mr. Boehner’s remarks held wider implications, effectively putting him on a war footing with the independent analysts whose calculations generally guide discussions about the projected cost or savings of any legislation.“I do not believe that repealing the job-killing health care law will increase the deficit,” he said. C.B.O. is entitled to their opinion,” he said, but he said Democrats had manipulated the rules established for determining the cost of a program under the 1974 Budget Act. “C.B.O. can only provide a score based on the assumptions that are given to them,” Mr. Boehner said. “And if you go back and look at the health care bill and the assumptions that were given to them, you see all of the double-counting that went on.” But the analysis released by the budget office on Thursday was based on the health care repeal bill that House Republicans introduced on Wednesday. And it highlighted the difficult position that Republicans are in as they try to address what they insist are the top two priorities of voters who elected them in November: cutting the deficit and undoing the health care law.
According to the budget office, those goals are contradictory. 

The budget office estimated that the health care law, including education provisions, would reduce deficits over 10 years by $143 billion. Tax increases and cuts in projected Medicare spending would more than offset the cost of extending health insurance to millions of Americans. The budget office projected that the law would result in even bigger savings beyond 2019.
Republicans have said they do not believe that many of the Medicare cuts will ever take hold. They say that government subsidies to help people buy health insurance will prove far costlier than the budget office has predicted, and that the Democrats wrote the law to mask the steep future costs of some provisions, like a new long-term-care insurance program.The budget office did not comment on Mr. Boehner’s remarks. Douglas W. Elmendorf, its director, has frequently said his office applies the longstanding budget rules. He says it uses its own professional expertise, as well as consulting with outside experts, to derive its projections, which represent the “middle of the distribution of likely outcomes.” Mr. Elmendorf has warned that Congress may find it difficult to follow through with parts of the health care law, particularly the cuts to Medicare. The law’s cost would rise if the cuts were not enacted.In the report on Thursday, Mr. Elmendorf, a former Clinton administration official appointed in 2008 when Democrats controlled both chambers of Congress, said that a preliminary analysis showed that repealing the law would increase federal budget deficits by a total of $145 billion from 2012 to 2019 and by $230 billion between 2012 and 2021.
Moreover, he said, if the law is repealed, 32 million fewer people will have health insurance in 2019, compared with estimates of coverage under the existing law. As a result, he said, the number of uninsured would be 54 million, rather 23 million, in 2019. 

At Mr. Boehner’s news conference, reporters peppered him with questions about repealing the law — including the cost analysis and a plan by Republicans not to allow amendments on the repeal measure even though the party had promised to maintain a more open legislative process.“Well, listen, I promised a more open process,” Mr. Boehner said. “I didn’t promise that every single bill was going to be an open bill.” 

Mr. Boehner grew testy when a reporter noted that Democrats who controlled the Senate were unlikely to bring up the repeal measure, let alone support it, and that Mr. Obama could veto it. “Don’t you think it’s a waste of time?” Mr. Boehner was asked. “No, I do not,” he said, raising his voice. “I believe it’s our responsibility to do what we said we were going to do. And I think it’s pretty clear to the American people that the best health care system in the world is going to go down the drain if we don’t act.” In their own report on Thursday, intended to illustrate how the law would lead to job losses, Republican leaders put the cost of the health care law “when fully implemented” at $2.6 trillion and said it would “add $701 billion to the deficit in its first 10 years.”



Thursday, January 6, 2011

NI Swine flu rate increases

Swine flu continues to rise in Northern Ireland, according to the latest figures from the Public Health Agency.A total of 185 people had the H1NI virus in the last week of December.This indicates an increase of 49 cases on the previous week. 
 
 
The rates are highest in the 15-44 age group. G.P consultation rates also shot up by 45% from 179.5 per 100,000 population.Receiving the seasonal flu vaccine is "the best way" to protect against the virus, according to Dr. Lorraine Doherty, PHA's Assistant Director.She recommends the injection for those in the 'at-risk' group which includes the over-65s and those with a lowered immune system.
 
 
NI Swine flu
 
Addressing concerns over the availability of the flu vaccine, she said: "I would like to stress that vaccines are still available and pregnant women in particular, no matter what stage of pregnancy, should receive the vaccine, even if they received the swine flu vaccine last year."And for those who have already contracted the illness, they have been advised to stay indoors. "If you do get flu this year, our advice is to stay at home and don't spread your infection to others," Dr. Doherty said.

"Rest, drink plenty of fluids and use over-the-counter remedies if they make you feel more comfortable."GPs and hospitals are busy dealing with flu cases, so I would emphasise that people should stay at home and contact their GP only if their condition worsens or if they are in an 'at risk' group or pregnant and not recovering. "Do not visit relatives or friends in hospital if you are sneezing, have a cough or have other symptoms of flu-like illness," she added. Meanwhile, intensive care and high dependency units throughout Northern Ireland are being taken over by flu sufferers. This has led to the postponement of elective surgery for one week to ensure hospitals continue to meet the needs of intensive care patients.

A total of 40% of beds in hospitals throughout the region were occupied by patients suffering from flu and flu-like symptoms on Wednesday morning, Belfast Health and Social Care confirmed.

Wednesday, January 5, 2011

Study Finds Correlation Between Cancer Development and Infection

In a recent study conducted by The City College of New York has successfully drawn parallels between infection and the way in which blood cancer advances in the body. This study specifically was carried out in fruit flies.

The immune system response in Drosophila to a wasp infection is highly restrained, resulting in a thin layer of blood cells encapsulating the egg.


However, blood cancer occurs when there is an out-of-control response to a chronic inflammation, with a much thicker layer of red blood cells.

"The response to wasp infection is similar to acute inflammation while the cancer is akin to chronic inflammation in mammals, where regulation of the response to an infection also goes out of control," said Dr. Shubha Govind.
Thin layer of blood cells encapsulating


The correct balance between positive and negative factors is achieved through sumoylation, Professor Govind and colleagues reported.

"There is strong evidence that the fundamental mechanism of regulation uncovered in flies also works in humans. Because of the molecular similarities between flies and mammals, it may be possible to use flies to test drugs for potential anti-inflammatory effects in human disease," Govind said.

Although cancer would still be incurable with such drugs, maybe its progression could be delayed.

Other potential applications are in pest control for agriculture - parasitoids with the ability to suppress the hosts' immune systems could be used to kill insect pests.

Estrogen Makes Precancerous Cells Deadly in the Oral Cavity

Researchers at Fox Chase Cancer Center have found that estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity.

Margie Clapper, co-leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center and colleagues had previously reported that estrogen metabolism changes following smoke exposure in the lungs and may contribute to lung cancer.

    Estrogen Makes Precancerous Cells Deadly



To find out if this female hormone influences development of head and neck cancer, Ekaterina Shatalova, of the Fox Chase Cancer Center and researcher on this study, examined the impact of estrogen on precancerous and cancerous cells.

They found that estrogen induces the expression of an enzyme called cytochrome P450 1B1 (CYP1B1), which is responsible for breaking down toxins and metabolizing estrogen.

Interestingly, CYP1B1 induction occurred only in precancerous cells, which are neither totally normal nor cancerous. Surprisingly, estrogen did not induce CYP1B1 in cancer cells.

With closer investigation, the researchers found that depleting the expression of CYP1B1 diminished the ability of precancerous cells to move and divide, as compared to similar cells with normal levels of CYP1B1.


Tuesday, December 14, 2010

Screening Can Save Few Ovarian Cancer Patients' Lives

In a recent research it has been stated that the best available screening tests reduces ovarian cancer death in a low frequency rate and saves few lives. The findings of the research also suggested that apart from screening tests, prevention and advanced treatment would significantly lower the number of women who die from ovarian cancer.

Screening Program for Ovarian Cancer


No screening program for ovarian cancer has been proven to save lives, mainly because the disease is uncommon and tends to grow and spread without causing symptoms. Laura Havrilesky, MD, MHSc, of the Duke University Medical Center in Durham, led a team that recently designed a computer-based model of the progression of ovarian cancer from early to late stages. The model, which takes into account the fact that certain ovarian cancers are slow growing while others grow more quickly, can test the effectiveness of screening strategies for reducing the number of deaths from ovarian cancer.

The researchers discovered that annual screening for ovarian cancer is likely to result in only a modest reduction in mortality from the disease. "If we assume ovarian cancers grow and spread at different rates, the best screening strategy available will only reduce the number of women dying from this cancer by 11 percent. This is partially because the slower growing cancers are more likely to be caught by a screening test," said Dr.Havrilesky.
The findings support the commonly held clinical impression that many early stage ovarian cancers are destined to remain in the early stages for some time, while advanced stage cancers have likely spread rapidly.



Triple Negative Breast Cancer Could be Tackled by Three-drug Combination

A combination of three drugs that could treat triple negative breast cancer has been tested by scientists at the John Hopkins Kimmel Cancer Center.Women with such cancers lack all three hormone receptors - estrogen , progesterone and human epidermal growth factor 2 (HER2) and currently, treatments for triple negative breast cancers are limited to surgery, chemotherapy and radiation, which provide some improvements but overall poor prognoses.
Treat Triple Negative Breast Cancer


In the new study, Johns Hopkins scientists began with a drug called Entinostat, which blocks an enzyme that unfolds DNA, providing regulatory molecules access to genes within and also reactivates a gene called retinoic acid receptor-beta (RAR-B). Thereafter, they added a drug called All Trans Retinoic Acid (ATRA), related to Vitamin A, which binds a protein made by the reactivated RAR-B gene.

Together, the ATRA drug and RAR-B gene act as a brake on cancer cell growth. The scientists completed the drug cocktail with conventional chemotherapy using either low doses of doxorubicin or paclitaxel.The scientists noted that using these drugs individually have some impact on the tumour but the combined impact tips the scale in favor of killing more cells.

Tests on laboratory-cultured cells showed that the triple combo therapy halted the growth of multiple triple negative breast cancer cell lines more effectively than any one of the treatments alone.


 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Macys Printable Coupons